Earnings summaries and quarterly performance for Cronos Group.
Executive leadership at Cronos Group.
Michael Gorenstein
Detailed
Chairman, President and Chief Executive Officer
CEO
AW
Adam Wagner
Detailed
Senior Vice President, Head of Cronos Israel
AS
Anna Shlimak
Detailed
Chief Financial Officer
AW
Arye Weigensberg
Detailed
Senior Vice President, Head of Research & Development
JJ
Jeff Jacobson
Detailed
Chief Growth Officer
SB
Shannon Buggy
Detailed
Senior Vice President, Global Head of People
TD
Terry Doucet
Detailed
General Counsel and Corporate Secretary
Board of directors at Cronos Group.
Research analysts who have asked questions during Cronos Group earnings calls.
YK
Yewon Kang
Canaccord Genuity
6 questions for CRON
Also covers: FFNTF, OGI, SNDL +1 more
BK
Bill Kirk
Roth Capital Partners, LLC
2 questions for CRON
Also covers: ACB, CGC, GO +8 more
KT
Kendrick Tai
Canaccord Genuity Capital Markets
2 questions for CRON
Pablo Zuanic
Zuanic & Associates
2 questions for CRON
Also covers: ACB, AFCG, CGC +15 more
RN
Ryan Neal
TD Cowen
2 questions for CRON
Recent press releases and 8-K filings for CRON.
Cronos Group Reports Record Q4 and Full-Year 2025 Results, Announces CanAdelaar Acquisition
CRON
Earnings
M&A
Share Buyback
- Cronos Group achieved a record year in 2025, with net revenue growing 25% organically and reaching record full-year gross profit and Adjusted EBITDA. For Q4 2025, consolidated net revenue increased 47% year-over-year to $44.5 million, with a 36% gross margin and $0.5 million Adjusted EBITDA.
- The company demonstrated strong market performance, with Canadian net revenue up 42% year-over-year in Q4 2025, driven by brands like Spinach, which became the number 2 overall vape brand nationally and achieved number 1 market share in vape cartridges. International markets also saw significant growth, with Israel's net revenue increasing 52% year-over-year and other international markets up 68% year-over-year.
- Cronos Group announced a definitive agreement to acquire CanAdelaar, the largest company in the Netherlands' legal adult-use cannabis program, for an upfront consideration of approximately $67.5 million USD, with closing anticipated in the first half of 2026. The company maintains a strong balance sheet with no debt and $832 million in cash equivalents and short-term investments, and is committed to its share repurchase program.
2 days ago
Cronos Group Reports Record 2025 Financials and Announces CanAdelaar Acquisition
CRON
Earnings
M&A
Revenue Acceleration/Inflection
- Cronos Group delivered a record year in 2025, with net revenue growing 25% organically and achieving record full-year gross profit and adjusted EBITDA.
- For Q4 2025, consolidated net revenue increased 47% year-over-year to $44.5 million, and adjusted EBITDA was $0.5 million, an improvement of $7.7 million year-over-year.
- The company maintains a strong financial position, ending Q4 2025 with $832 million in cash equivalents and short-term investments.
- Cronos Group entered into a definitive agreement to acquire CanAdelaar for EUR 57.5 million (approximately $67.5 million USD), a market leader in the Netherlands' legal adult-use cannabis program, with closing expected in the first half of 2026.
- The Spinach brand demonstrated strong performance in Canada, becoming the second most popular brand nationally, achieving number one market share in vape cartridges in Q4 2025, and its SOURZ edibles maintaining category leadership with nearly 22% market share.
2 days ago
Cronos Group Reports Record Q4 and Full Year 2025 Results, Announces CanAdelaar Acquisition
CRON
Earnings
M&A
Revenue Acceleration/Inflection
- Cronos Group reported record net revenue for both Q4 and full year 2025, with full-year organic growth of 25% and Q4 consolidated net revenue up 47% year-over-year to $44.5 million.
- The company achieved record full-year gross profit and Adjusted EBITDA in 2025, ending Q4 with a strong balance sheet of $832 million in cash equivalents and short-term investments and no debt.
- Cronos entered into a definitive agreement to acquire CanAdelaar, the largest company in Netherlands' legal adult-use cannabis program, for EUR 57.5 million (approximately USD 67.5 million), with closing expected in H1 2026.
- Canadian net revenue grew 42% year-over-year, driven by brands like Spinach, which became the number 2 overall vape brand. International net revenue also saw significant growth, up 52% in Israel and 68% in other markets year-over-year.
- The company expects full year 2025 Adjusted gross margin of 43% to be a reasonable level going forward, with potential for expansion from the CanAdelaar acquisition, and plans to continue its share repurchase program.
2 days ago
Cronos Group Reports Record 2025 Fourth Quarter and Full-Year Results and Announces Acquisition
CRON
Earnings
Revenue Acceleration/Inflection
M&A
- Cronos Group reported record net revenue of $44.5 million in Q4 2025, a 47% increase year-over-year, and $146.6 million for the full year 2025, a 25% increase year-over-year.
- The company achieved a full-year 2025 Adjusted EBITDA of $10.1 million, an improvement of $45.1 million from full-year 2024, while reporting a net loss of $2.9 million for the full year 2025.
- Cronos Group maintained a strong balance sheet with $832 million in cash and cash equivalents and short-term investments as of December 31, 2025.
- The company entered into a definitive agreement in Q4 2025 to acquire CanAdelaar B.V. for approximately $67 million up-front cash consideration, establishing a strategic footprint in Europe and expanding into the Netherlands' legal adult-use cannabis market.
2 days ago
Cronos Group Inc. to Acquire CanAdelaar, Expanding into European Cannabis Market
CRON
M&A
New Projects/Investments
Revenue Acceleration/Inflection
- Cronos Group Inc. (CRON) announced it will acquire CanAdelaar B.V., the largest adult-use cannabis company operating within the Netherlands' adult-use cannabis pilot program, for an up-front cash consideration of US$67.0 million (€57.5 million).
- The acquisition includes additional contingent cash consideration payable based on 0.5x CanAdelaar's normalized EBITDA in 2026 and 2027.
- This transaction is expected to provide Cronos with the #1 market share in Europe's largest adult-use cannabis market.
- CanAdelaar reported revenue of US$47.3 million and EBITDA of US$28.2 million for the twelve months ended September 30, 2025.
- The acquisition is anticipated to close in the first half of 2026.
Dec 9, 2025, 12:32 PM
Cronos Announces Acquisition of CanAdelaar
CRON
M&A
New Projects/Investments
- Cronos Group Inc. announced its wholly-owned subsidiary will acquire CanAdelaar B.V. for an up-front cash consideration of US$67.0 million (or €57.5 million), with additional contingent consideration based on 0.5x CanAdelaar's normalized EBITDA in 2026 and 2027.
- CanAdelaar is the largest cannabis company operating within the Netherlands' adult-use cannabis pilot program, the Wietexperiment, and the acquisition is expected to give Cronos the #1 market share in Europe's largest adult-use cannabis market.
- The acquisition provides a strategic footprint in Europe, enabling Cronos to leverage its investments in genetics and R&D through a borderless product strategy.
- CanAdelaar generated US$17.7 million in revenue and US$8.0 million in EBITDA in 2024, growing to US$47.3 million in revenue and US$28.2 million in EBITDA for the twelve months ended September 30, 2025.
- The transaction is expected to close in early 2026, subject to customary closing conditions and regulatory clearances.
Dec 9, 2025, 12:30 PM
Cronos Group Reports Record Q3 2025 Net Revenue and Improved Profitability
CRON
Earnings
Revenue Acceleration/Inflection
New Projects/Investments
- Cronos Group reported consolidated net revenue of $36.3 million in Q3 2025, marking a 6% increase year over year, primarily driven by strong cannabis flower sales in Israel and extract sales in Canada.
- The company achieved a gross profit of $18.3 million, equating to a 50% gross margin, a 19 percentage point improvement from Q3 2024, and Adjusted EBITDA of $5.7 million, an $11.7 million year-over-year improvement.
- Cronos Group maintains a strong financial position with $824 million in cash, cash equivalents, and short-term investments as of Q3 2025.
- The phase two expansion at GrowCo is complete, with flower sales starting in fall 2025, and is anticipated to drive improved flower sales in 2026 due to a 70% capacity increase.
Nov 6, 2025, 1:30 PM
Cronos Group Reports Record Q3 2025 Net Revenue, Gross Profit, and Adjusted EBITDA
CRON
Earnings
Revenue Acceleration/Inflection
New Projects/Investments
- Cronos Group Inc. achieved record levels of consolidated net revenue, gross profit, and Adjusted EBITDA in Q3 2025. Net revenue increased by 9% quarter-over-quarter and 6% year-over-year to $36.3 million.
- The company reported a gross profit of $18.3 million and Adjusted EBITDA of $5.7 million in Q3 2025, representing increases of $14.7 million and $11.7 million respectively, compared to Q3 2024.
- Cronos maintains a strong balance sheet with $824 million in total cash and cash equivalents and short-term investments as of September 30, 2025.
- Israel generated record-high net revenue, with the PEACE NATURALS® brand remaining the number one cannabis brand in the market. In Canada, the Spinach® brand held the #2 overall market share, leading the edibles category with a 19.7% market share and ranking #3 in vapes with a 7.0% share.
- The Cronos GrowCo expansion is complete, with sales commencing in Fall 2025, expected to fuel growth in 2026.
Nov 6, 2025, 12:32 PM
Trump Media, Crypto.com, and Yorkville Launch CRO Treasury Company
CRON
New Projects/Investments
Debt Issuance
- Trump Media Group, in partnership with Crypto.com and Yorkville Acquisition Corp., has launched Trump Media Group CRO Strategy Inc., a $6.42 billion digital asset treasury company focused exclusively on the Cronos (CRO) token, which will be publicly traded under the ticker MCGA.
- The company aims to build a treasury of at least $6.42 billion, funded by $1 billion in CRO tokens, $420 million in cash and warrants, and a $5 billion equity line of credit from YA II PN, Ltd..
- Trump Media will run a validator node on the Cronos blockchain, stake its CRO holdings to generate additional revenue, and integrate CRO into its Truth Social platform through a new rewards system that allows users to convert platform points into CRO tokens, with future plans for subscription payments and discounted services using CRO.
- Founding shareholders have agreed to a one-year lock-up period followed by a three-year release schedule, highlighting a long-term commitment to the initiative.
Aug 26, 2025, 12:46 PM
Quarterly earnings call transcripts for Cronos Group.
Ask Fintool AI Agent
Get instant answers from SEC filings, earnings calls & more